- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
-
- 长期趋势：
已有540家主力机构披露2024-12-31报告期持股数据，持仓量总计10.29亿股，占流通A股80.68%
- 波段诊断：
-
技术面诊股
诊断结果：2.4技术面打败了11%的股票
技术面评分前10的股票
近期的平均成本为31.22元。
平均成本
近期的平均成本为31.22元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"31.22","date":1751270173,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，跑输行业平均水平。
[{"date":"2025.07.01","stock":"-0.26","trade":"1.61","ind":"0.11"},{"date":"2025.06.30","stock":"-0.89","trade":"0.30","ind":"0.83"},{"date":"2025.06.27","stock":"-0.91","trade":"0.38","ind":"0.34"},{"date":"2025.06.26","stock":"0.31","trade":"-0.51","ind":"-0.48"},{"date":"2025.06.25","stock":"1.15","trade":"0.24","ind":"1.72"},{"date":"2025.06.24","stock":"1.49","trade":"1.40","ind":"1.68"},{"date":"2025.06.23","stock":"-0.61","trade":"0.71","ind":"0.43"},{"date":"2025.06.20","stock":"0.91","trade":"-0.05","ind":"-0.47"},{"date":"2025.06.19","stock":"-0.58","trade":"-1.61","ind":"-1.21"},{"date":"2025.06.18","stock":"-0.58","trade":"-1.39","ind":"0.24"},{"date":"2025.06.17","stock":"-0.48","trade":"-0.79","ind":"-0.12"},{"date":"2025.06.16","stock":"-0.95","trade":"-0.34","ind":"0.41"},{"date":"2025.06.13","stock":"-1.59","trade":"-2.44","ind":"-1.10"},{"date":"2025.06.12","stock":"-1.62","trade":"0.26","ind":"-0.11"},{"date":"2025.06.11","stock":"-1.21","trade":"0.22","ind":"0.83"},{"date":"2025.06.10","stock":"0.27","trade":"0.01","ind":"-0.86"},{"date":"2025.06.09","stock":"0.95","trade":"2.07","ind":"0.65"},{"date":"2025.06.06","stock":"-1.00","trade":"0.04","ind":"-0.19"},{"date":"2025.06.05","stock":"1.03","trade":"-1.48","ind":"0.58"},{"date":"2025.06.04","stock":"-0.70","trade":"0.55","ind":"0.87"},{"date":"2025.06.03","stock":"0.35","trade":"2.14","ind":"0.16"}]
华润三九,深证成指,中药指数
压力支撑
该股压力位为31.19元，支撑位为31.01元。
[{"text":"\u538b\u529b\u4f4d","value":"31.19","date":1751299200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"31.01","date":1751299200,"color":"0x0b52a1"}]
多空趋势
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.0资金面打败了6%的股票
主力控盘前10的股票
行业资金
中药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：07月02日 08:11
| 机构今日流向(万元) | 654.41 | 机构5日流向(万元) | -2465.17 |
| 机构10日流向(万元) | -7302.27 | 机构20日流向(万元) | -22703.14 |
机构持仓
2024-12-31 与 2024-06-30 相比，主力机构持仓量减少3306.09万股，其中基金净减仓47家，主力净减仓31家，请投资者中长期谨慎为宜。
截止2024-12-31，共540家主力机构（基金537家，一般法人2家，社保基金1家），持仓量总计102913.4万股，占流通A股80.68%
其中，基金持仓与2024-06-30相比：
增仓：135家 ，增持 1905.45万股
减仓：182家 ，减持 3853.85万股
新出现在主力名单中：198家 ，持有1853.2万股
从主力名单中消失：229家 ，原持有1486.64万股
其中，基金持仓与2024-06-30相比：
增仓：135家 ，增持 1905.45万股
减仓：182家 ，减持 3853.85万股
新出现在主力名单中：198家 ，持有1853.2万股
从主力名单中消失：229家 ，原持有1486.64万股
消息面诊股
诊断结果：5.6消息面打败了8%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 华润三九（截止2025年6月30日）股东人数为65
2025-07-01 - 华润三九：公司海外业务在公司总体业务中占比较小
2025-07-01 - 华润三九：6月30日获融资买入1977.97万元
2025-07-01 - 华润三九：6月27日获融资买入1366.99万元
2025-06-30 - 联合开发自研iPSC心肌细胞药 华润三九拓展千亿蓝
2025-06-30 - 行业追踪|中医药市场（6月23日-6月29日）：综
2025-06-29 - 国药、华润医药接连大动作，专业化整合背后深意在哪里
2025-06-27 - 券商观点|医药生物行业双周报：25省中成药集采落地
2025-06-27 - 行业周报|中药指数涨2.23%, 跑赢上证指数0.
2025-06-27 - 华润三九拓展千亿蓝海赛道：联合开发中国首款自研iP
2025-06-27
消息列表
| 一般消息 | 高管变动 | 由于工作调整原因 | 2025-06-24 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-06-17 |
| 一般消息 | 重大事项 | 关联交易 | 2025-05-15 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-04-01 |
| 利好 | 分红转增 | 10转3股派3.2元(含税) | 2025-03-13 |
| 一般消息 | 重大事项 | 关联交易 | 2025-01-18 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-12-31 |
| 一般消息 | 重大事项 | 关联交易 | 2024-12-26 |
| 一般消息 | 高管变动 | 由于工作变动 | 2024-11-29 |
| 利好 | 分红转增 | 10派10元(含税) | 2024-10-26 |
| 一般消息 | 高管变动 | 工作安排原因 | 2024-10-24 |
| 一般消息 | 高管变动 | 工作变动原因 | 2024-09-06 |
| 一般消息 | 分红转增 | 不分配不转增 | 2024-08-24 |
| 一般消息 | 高管变动 | 工作变动 | 2024-08-09 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 0条 | 3条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：6.3行业面打败了75%的股票
中药行业最新资金流向
近10日来该行业走势不明显，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑输大盘。
[{"date":"2025.07.01","price":"0.11","value":"1.61"},{"date":"2025.06.30","price":"0.83","value":"0.30"},{"date":"2025.06.27","price":"0.34","value":"0.38"},{"date":"2025.06.26","price":"-0.48","value":"-0.51"},{"date":"2025.06.25","price":"1.72","value":"0.24"},{"date":"2025.06.24","price":"1.68","value":"1.40"},{"date":"2025.06.23","price":"0.43","value":"0.71"},{"date":"2025.06.20","price":"-0.47","value":"-0.05"},{"date":"2025.06.19","price":"-1.21","value":"-1.61"},{"date":"2025.06.18","price":"0.24","value":"-1.39"},{"date":"2025.06.17","price":"-0.12","value":"-0.79"},{"date":"2025.06.16","price":"0.41","value":"-0.34"},{"date":"2025.06.13","price":"-1.10","value":"-2.44"},{"date":"2025.06.12","price":"-0.11","value":"0.26"},{"date":"2025.06.11","price":"0.83","value":"0.22"},{"date":"2025.06.10","price":"-0.86","value":"0.01"},{"date":"2025.06.09","price":"0.65","value":"2.07"},{"date":"2025.06.06","price":"-0.19","value":"0.04"},{"date":"2025.06.05","price":"0.58","value":"-1.48"},{"date":"2025.06.04","price":"0.87","value":"0.55"},{"date":"2025.06.03","price":"0.16","value":"2.14"}]
深证成指,中药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 万邦德 | 194.54% | 4.78% | 5.0分 |
| 2 | 贵州百灵 | 42.14% | 17.77% | 5.0分 |
| 3 | 恩威医药 | 21.54% | 10.57% | 5.0分 |
| 4 | 启迪药业 | 15.31% | 7.69% | 5.1分 |
| 5 | 众生药业 | 14.10% | 1.23% | 4.8分 |
| 6 | 康缘药业 | 13.18% | 1.99% | 4.5分 |
| 8 | - | 4.39% | 4.39% | 分 |
| 10 | 济川药业 | 2.73% | 2.41% | 5.5分 |
| 12 | 珍宝岛 | 2.25% | 0.26% | 4.8分 |
| 14 | *ST长药 | 2.00% | 5.77% | 4.5分 |
| 16 | 天目药业 | 1.72% | 1.42% | 5.5分 |
| 18 | 太龙药业 | 0.88% | -1.38% | 4.0分 |
| 20 | 仁和药业 | 0.18% | 1.10% | 4.7分 |
| 22 | 太极集团 | -0.37% | -1.11% | 4.3分 |
| 24 | 益佰制药 | -0.75% | 3.10% | 4.8分 |
| 26 | 嘉应制药 | -0.95% | 1.80% | 4.9分 |
| 28 | 粤万年青 | -1.47% | 3.00% | 4.3分 |
| 30 | 华神科技 | -1.76% | 1.56% | 4.5分 |
| 32 | 信邦制药 | -1.95% | 1.73% | 4.5分 |
| 34 | 上海凯宝 | -2.06% | 1.98% | 4.8分 |
| 36 | 贵州三力 | -2.33% | 1.03% | 5.4分 |
| 38 | 特一药业 | -2.39% | 0.00% | 4.5分 |
| 40 | 云南白药 | -2.53% | 0.67% | 4.9分 |
| 42 | 中恒集团 | -2.66% | 1.19% | 4.1分 |
| 44 | 步长制药 | -3.09% | 0.56% | 5.1分 |
| 46 | 健民集团 | -3.73% | 1.02% | 4.3分 |
| 48 | 同仁堂 | -4.01% | 0.72% | 4.8分 |
| 50 | ST香雪 | -4.16% | -1.19% | 3.9分 |
| 52 | 江中药业 | -4.46% | 0.00% | 4.5分 |
| 54 | 以岭药业 | -4.77% | 0.50% | 4.6分 |
| 56 | 马应龙 | -5.29% | 0.04% | 4.7分 |
| 58 | 方盛制药 | -5.95% | 0.40% | 4.3分 |
| 60 | 寿仙谷 | -6.43% | -0.14% | 3.8分 |
| 62 | 昆药集团 | -7.62% | 1.39% | 4.2分 |
| 64 | 佛慈制药 | -9.95% | 1.09% | 4.3分 |
| 66 | - | -21.92% | -3.26% | 分 |
| 68 | 广誉远 | - | 2.42% | 5.1分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-03-31 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 5/112 ， 35/112。
[{"date":"2025-03-31","value":"6.18","vol":"2.23"},{"date":"2024-12-31","value":"17.33","vol":"5.32"},{"date":"2024-09-30","value":"14.99","vol":"2.95"},{"date":"2024-06-30","value":"12.32","vol":"1.60"},{"date":"2024-03-31","value":"6.94","vol":"1.67"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
6.18 | 17.33 | 14.99 | 12.32 | 6.94 |
| 行业(%) | 2.23 | 5.32 | 2.95 | 1.60 | 1.67 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"53.28","vol":"53.01"},{"date":"2024-12-31","value":"51.86","vol":"52.47"},{"date":"2024-09-30","value":"52.68","vol":"52.77"},{"date":"2024-06-30","value":"53.56","vol":"53.17"},{"date":"2024-03-31","value":"53.42","vol":"53.62"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
53.28 | 51.86 | 52.68 | 53.56 | 53.42 |
| 行业(%) | 53.01 | 52.47 | 52.77 | 53.17 | 53.62 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 35/112 ， 36/112。
[{"date":"2025-03-31","value":"-6.04","vol":"-5.22"},{"date":"2024-12-31","value":"11.63","vol":"-6.80"},{"date":"2024-09-30","value":"6.08","vol":"-4.36"},{"date":"2024-06-30","value":"7.30","vol":"-4.12"},{"date":"2024-03-31","value":"14.82","vol":"-2.27"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-6.04 | 11.63 | 6.08 | 7.30 | 14.82 |
| 行业(%) | -5.22 | -6.80 | -4.36 | -4.12 | -2.27 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"-6.87","vol":"-35.55"},{"date":"2024-12-31","value":"18.05","vol":"-101.25"},{"date":"2024-09-30","value":"23.19","vol":"-6.00"},{"date":"2024-06-30","value":"27.77","vol":"-15.66"},{"date":"2024-03-31","value":"18.49","vol":"-9.41"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-6.87 | 18.05 | 23.19 | 27.77 | 18.49 |
| 行业(%) | -35.55 | -101.25 | -6.00 | -15.66 | -9.41 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 22/112 ， 33/112。
[{"date":"2025-03-31","value":"0.14","vol":"0.12"},{"date":"2024-12-31","value":"0.69","vol":"0.49"},{"date":"2024-09-30","value":"0.49","vol":"0.37"},{"date":"2024-06-30","value":"0.35","vol":"0.26"},{"date":"2024-03-31","value":"0.18","vol":"0.13"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.14 | 0.69 | 0.49 | 0.35 | 0.18 |
| 行业(次) | 0.12 | 0.49 | 0.37 | 0.26 | 0.13 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"0.55","vol":"0.62"},{"date":"2024-12-31","value":"2.65","vol":"2.41"},{"date":"2024-09-30","value":"1.84","vol":"1.80"},{"date":"2024-06-30","value":"1.30","vol":"1.24"},{"date":"2024-03-31","value":"0.67","vol":"0.66"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.55 | 2.65 | 1.84 | 1.30 | 0.67 |
| 行业(次) | 0.62 | 2.41 | 1.80 | 1.24 | 0.66 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-03-31","value":"14.30","vol":"2.34"},{"date":"2024-12-31","value":"15.21","vol":"15.76"},{"date":"2024-09-30","value":"14.93","vol":"6.40"},{"date":"2024-06-30","value":"23.14","vol":"11.96"},{"date":"2024-03-31","value":"10.78","vol":"1.49"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 14.30 | 15.21 | 14.93 | 23.14 | 10.78 |
| 行业 | 2.34 | 15.76 | 6.40 | 11.96 | 1.49 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.88","vol":"1.45"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"0.73","vol":"1.38"},{"date":"2024-03-31","value":"","vol":"0.00"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.88 | - | 0.73 | - |
| 行业 | 0.00 | 1.45 | 0.00 | 1.38 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 24/112 ， 5/112。
[{"date":"2025-03-31","value":"1.46","vol":"2.97"},{"date":"2024-12-31","value":"1.61","vol":"2.87"},{"date":"2024-09-30","value":"1.88","vol":"3.19"},{"date":"2024-06-30","value":"1.84","vol":"2.92"},{"date":"2024-03-31","value":"1.88","vol":"2.96"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
1.46 | 1.61 | 1.88 | 1.84 | 1.88 |
| 行业 | 2.97 | 2.87 | 3.19 | 2.92 | 2.96 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"1.08","vol":"2.19"},{"date":"2024-12-31","value":"1.17","vol":"2.09"},{"date":"2024-09-30","value":"1.40","vol":"2.38"},{"date":"2024-06-30","value":"1.37","vol":"2.20"},{"date":"2024-03-31","value":"1.41","vol":"2.26"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
1.08 | 1.17 | 1.40 | 1.37 | 1.41 |
| 行业 | 2.19 | 2.09 | 2.38 | 2.20 | 2.26 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 15/112 ， 11/112。
[{"date":"2025-03-31","value":"38.91","vol":"33.51"},{"date":"2024-12-31","value":"36.99","vol":"34.19"},{"date":"2024-09-30","value":"36.07","vol":"33.21"},{"date":"2024-06-30","value":"37.65","vol":"34.04"},{"date":"2024-03-31","value":"37.63","vol":"33.28"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
38.91 | 36.99 | 36.07 | 37.65 | 37.63 |
| 行业(%) | 33.51 | 34.19 | 33.21 | 34.04 | 33.28 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"1.06","vol":"0.73"},{"date":"2024-12-31","value":"0.74","vol":"0.75"},{"date":"2024-09-30","value":"0.72","vol":"3.21"},{"date":"2024-06-30","value":"0.77","vol":"1.65"},{"date":"2024-03-31","value":"0.76","vol":"0.98"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
1.06 | 0.74 | 0.72 | 0.77 | 0.76 |
| 行业(%) | 0.73 | 0.75 | 3.21 | 1.65 | 0.98 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 华泰金融(HK) | 2025-06-27 | 增持 | |
| 华泰证券 | 2025-06-25 | 增持 | |
| 中信建投证券 | 2025-05-19 | 买入 | |
| 国信证券 | 2025-05-09 | 买入 | 买入 |
| 万联证券 | 2025-05-06 | 买入 | |
| 野村东方国际证券 | 2025-05-06 | 增持 |
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"20.47","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"24.49","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"28.53","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"33.68","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"38.59","blueLineValue":"2.31","type":"YC"}]